The PPRI Pharma Brief Austria 2026 is now available in German, providing a concise and accessible overview of the Austrian pharmaceutical system for German-speaking audiences.
Based on the English country report, the publication covers the key features of Austria's pharmaceutical pricing and reimbursement system, including pricing and price regulation, reimbursement in outpatient and inpatient care, Health Technology Assessment (HTA) procedures and the Federal Appraisal Board, as well as recent policy developments. It also includes key indicators on the Austrian pharmaceutical market.
The Brief is available for download here: https://ppri.goeg.at/ppri_pharma_profiles
The Pharma Brief is part of the Pharma Brief series of the PPRI network. The Pharma Brief series aims to support policymakers, public authorities, researchers and other stakeholders with concise information on national pharmaceutical systems.